Dashboard/Curaleaf Holdings, Inc.

CURLD - Curaleaf Holdings, Inc.

$10.12
0.03 0.301%
Share volume: 89,574
Last Updated: 09-15-2026
Pharmaceutical Products/Medicinal Chemicals:0.37%
-------
$8.23$8.90$9.58$10.26$10.93
06-17-202606-18-202606-22-202606-23-202606-24-202606-25-202606-26-202606-29-202606-30-202607-01-202607-02-202607-07-202607-08-202607-09-202607-10-202607-13-202607-14-202607-15-202607-16-202607-17-202607-20-202607-21-202607-22-202607-23-202607-24-202607-27-202607-28-202607-29-202607-30-202607-31-202608-03-202608-04-202608-05-202608-06-202608-07-202608-10-202608-11-202608-12-202608-13-202608-14-202608-17-202608-18-202608-19-202608-20-202608-21-202608-24-202608-25-202608-26-202608-27-202608-28-202608-31-202609-01-202609-02-202609-03-202609-04-202609-08-202609-09-202609-10-202609-11-202609-14-202609-15-2026

Key data

Stock price$10.12
P/E ratio475.8forward
Day range$9.87 - $10.12
EPS$-0.21
52 week range$1.80 - $12.45
52 week change288.38 %
Market cap2.926 B
YieldN/A
Shares outstanding724.125 M
DividendN/A
Ex-dividend dateN/A
Next earnings dateN/A
BetaN/A
Public floatN/A
Average 10 volume139,776
Average 30 volume197,904

Company detail

CEO
Matt Darin
Region
US
Website
curaleaf.com
Employees
5,600
IPO year
2018
Issue type
Market
OTCM
Industry
Pharmaceutical Products/Medicinal Chemicals
Sector
Manufacturing

Curaleaf Holdings, Inc. operates as an integrated medical and wellness cannabis operator in the United States. It operates in two segments, Cannabis Operations and Non-Cannabis Operations. The Cannabis Operations segment engages in the production and sale of cannabis through retail and wholesale channels. The Non-Cannabis Operations segment provides professional services, including cultivation, processing, and retail know-how and back office administration, intellectual property licensing, real estate leasing services, and lending facilities to medical and adult-use cannabis licensees under management service agreements. It offers oil-based formulations, such as vaporizing, cartridges, tinctures, and capsules; and ground-flower. The company also provides hemp-based CBD products. As of March 9, 2021, it operated 101 dispensaries, 23 cultivation sites, and 30 processing sites in 23 states of the United States. The company was founded in 2010 and is headquartered in Wakefield, Massachusetts.

Recent news

Curaleaf Bolsters Florida Footprint with Two New Medical Dispensaries in Jacksonville Beach and Fernandina Beach

Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer cannabis products, today announced the opening of two new medical dispensaries in Florida, one in Jacksonville Beach and the other in Fernandina Beach. The two new locations bring the Company's Florida footprint to 73 dispensaries and its nationwide total to 165 stores.

05-08-2026
Read more

Curaleaf Holdings’ Q1 Profit Turnaround And Expansion Spark Fresh Look At Valuation

Curaleaf’s earnings jump and international expansion draw investor focus Curaleaf Holdings (TSX:CURA) has moved into the spotlight after reporting a profitable first quarter of 2026, beating consensus expectations on both earnings and revenue and reversing a loss from a year earlier. See our latest analysis for Curaleaf Holdings. The earnings surprise and full buyout of German subsidiary Four 20 Pharma have arrived a […]

05-07-2026
Read more

Is It Too Late To Reconsider Curaleaf Holdings (TSX:CURA) After Its 1 Year Surge

If you are wondering whether Curaleaf Holdings at around US$5.18 reflects its true worth, the recent share performance and a low valuation score raise some important questions. The stock has posted returns of 15.6% over 7 days, 52.8% over 30 days, 44.7% year to date and 335.3% over 1 year. Over 3 years the return is 48.4% and over 5 years the return is a 70.3% decline. These moves have come as investors continue to r […]

05-07-2026
Read more

Curaleaf Holdings (TSX:CURA) Is Up 15.6% After Swinging to Q1 Profit and Expanding in Europe

Curaleaf Holdings, Inc. has reported first-quarter 2026 results, with revenue of US$324.23 million and net income of US$69.8 million, marking a move from prior losses to earnings of US$0.09 per share. Alongside this return to profitability, Curaleaf completed the full acquisition of German medical cannabis producer Four 20 Pharma, consolidating its European platform and expanding its international medical cannabis fo […]

05-07-2026
Read more

Curaleaf Holdings, Inc. (CURLF) Q1 Earnings and Revenues Top Estimates

Curaleaf Holdings, Inc. (CURLF) delivered earnings and revenue surprises of +220.00% and +2.40%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

05-05-2026
Read more

Curaleaf Reports First Quarter 2026 Results: Robust Growth and Net Income

Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer products in cannabis, today reported its financial and operating results for the first quarter ended March 31, 2026. All financial information is reported in accordance with U.S. generally accepted accounting principles ("U.S. GAAP" or "GAAP") and is provided in U.S. dollars unless otherwise […]

05-05-2026
Read more

Curaleaf Announces Appointment of Torsten Greif to Board of Directors

Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer cannabis products, today announced the appointment of Torsten Greif to the Curaleaf Board of Directors.

05-01-2026
Read more

Curaleaf Completes Buyout of Remaining Stake in Germany's Four 20 Pharma

Curaleaf Holdings, Inc (TSX: CURA) (OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer products in cannabis, has completed the buyout of the remaining 45% stake not previously owned in Four 20 Pharma GmbH, a fully EU-GMP and GDP licensed German producer and distributor of medical cannabis. Four 20 Pharma is recognized for its high-quality cultivation, pharmaceutical-grade proces […]

04-30-2026
Read more

Curaleaf Announces Date of Annual and Special Shareholders Meeting

Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer cannabis products, today announces that the Annual and Special Meeting of its shareholders (the "Meeting") will be held on Monday, June 22, 2026, at 9:00 a.m. (Eastern time) in a virtual format.

04-30-2026
Read more